当前位置: X-MOL 学术Toxins › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
BmK86-P1, a New Degradation Peptide with Desirable Thermostability and Kv1.2 Channel-Specific Activity from Traditional Chinese Scorpion Medicinal Material
Toxins ( IF 4.2 ) Pub Date : 2021-08-30 , DOI: 10.3390/toxins13090610
Chenhu Qin 1, 2 , Xuhua Yang 1 , Zheng Zuo 1 , Liuting Yang 1 , Fan Yang 1 , Zhijian Cao 1 , Zongyun Chen 1, 2 , Yingliang Wu 1, 3
Affiliation  

Thermally processed Buthus martensii Karsch scorpions are a traditional Chinese medical material for treating various diseases. However, their pharmacological foundation remains unclear. Here, a new degraded peptide of scorpion toxin was identified in Chinese scorpion medicinal material by proteomics. It was named BmK86-P1 and has six conserved cysteine residues. Homology modeling and circular dichroism spectra experiments revealed that BmK86-P1 not only contained representative disulfide bond-stabilized α-helical and β-sheet motifs but also showed remarkable stability at test temperatures from 20–95 °C. Electrophysiology experiments indicated that BmK86-P1 was a highly potent and selective inhibitor of the hKv1.2 channel with IC50 values of 28.5 ± 6.3 nM. Structural and functional dissection revealed that two residues of BmK86-P1 (i.e., Lys19 and Ile21) were the key residues that interacted with the hKv1.2 channel. In addition, channel chimeras and mutagenesis experiments revealed that three amino acids (i.e., Gln357, Val381 and Thr383) of the hKv1.2 channel were responsible for BmK86-P1 selectivity. This research uncovered a new bioactive peptide from traditional Chinese scorpion medicinal material that has desirable thermostability and Kv1.2 channel-specific activity, which strongly suggests that thermally processed scorpions are novel peptide resources for new drug discovery for the Kv1.2 channel-related ataxia and epilepsy diseases.

中文翻译:

BmK86-P1,一种来自中药蝎子药材的具有理想热稳定性和Kv1.2通道特异性活性的新型降解肽

经热处理的马氏全蝎是治疗各种疾病的中药材。然而,它们的药理基础仍不清楚。在这里,通过蛋白质组学在中药蝎药材中鉴定出一种新的蝎毒素降解肽。它被命名为 BmK86-P1,具有六个保守的半胱氨酸残基。同源建模和圆二色光谱实验表明,BmK86-P1 不仅含有代表性的二硫键稳定的 α-螺旋和 β-折叠基序,而且在 20-95°C 的测试温度下表现出显着的稳定性。电生理学实验表明,BmK86-P1 是一种高效、选择性的 hKv1.2 通道抑制剂,IC 50值为 28.5 ± 6.3 nM。结构和功能剖析显示BmK86-P1 的两个残基(即Lys 19和Ile 21)是与hKv1.2 通道相互作用的关键残基。此外,通道嵌合体和诱变实验表明,三种氨基酸(即 Gln 357、Val 381和 Thr 383) hKv1.2 通道负责 BmK86-P1 选择性。本研究从中药蝎子药材中发现了一种新的生物活性肽,具有良好的热稳定性和Kv1.2通道特异性活性,这强烈表明热处理的蝎子是Kv1.2通道相关性共济失调新药发现的新型肽资源。和癫痫病。
更新日期:2021-08-30
down
wechat
bug